BeStock  
Stocks › Biotechnology › ORIC

Oric Pharmaceuticals ORIC

US equityMarket cap rank #3332Biotechnology
$7.36 −$0.34 (-4.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.37 +0.14%
Open$7.58
Prev close$7.70
Day range$7.28 – $8.00
Volume1.46M
Market cap$764.94M
P/E (TTM)–
Dividend yield–

ORIC Stock News

Headlines matching Oric Pharmaceuticals or the ORIC ticker, most recent first.

  • BTIG Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $26Market news · 23 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $23Market news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Oric Pharmaceuticals(ORIC.US), With a Forecast Between $14 to $25Market news · 5 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Raises Target Price to $27 PositiveMarket news · 10 Aug 2026 · Direct mention
  • HC Wainwright & Co. Maintains Buy on ORIC Pharmaceuticals, Raises Price Target to $27 PositiveBenzinga · 10 Aug 2026 · Direct mention
  • HC Wainwright & Co. Reiterates Buy on ORIC Pharmaceuticals, Maintains $25 Price TargetBenzinga · 8 Jun 2026 · Direct mention
  • Goldman Sachs Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $15Market news · 3 Jun 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Tactile Systems Technology (TCMD) and Oric Pharmaceuticals (ORIC)TipRanks · 3 Jun 2026 · Direct mention
  • Piper Sandler Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $22Market news · 29 Jun 2026 · Direct mention
  • H.C. Wainwright Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $25Market news · 24 Jun 2026 · Direct mention
  • Stifel Initiates Oric Pharmaceuticals(ORIC.US) With Buy Rating, Announces Target Price $14Market news · 12 Jun 2026 · Direct mention
  • Stifel Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $14Market news · 12 Jun 2026 · Direct mention
  • Wells Fargo Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $25Market news · 11 Jun 2026 · Direct mention
  • Oppenheimer Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $15Market news · 5 May 2026 · Direct mention
  • Goldman Sachs Initiates Oric Pharmaceuticals(ORIC.US) With Buy RatingMarket news · 15 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on ORIC.

Sign in to join the discussion.

Scroll to Top